Tuesday, August 31, 2021 at 2pm EDT | 1pm CDT | 11am PDT Topical CBD has allowed brands to capture mass-market consumers with a trending ingredient, but entering the CBD space in any format is not without its challenges. Here’s what you need to know to successfully and responsibly market topical CBD.
Register Free: https://www.nutritionaloutlook.com/no/pitfalls
There’s no stopping CBD as products in multiple formats proliferate across different channels. Growth in the mainstream market has been slower, however, as major retailers take a cautious approach to the ingredient. Topically applied CBD products provided brands a viable pathway into the CBD space and the mass market when retailers such as CVS began accepting them as inventory in 2019. However, topical CBD products have not been immune to the scrutiny of regulators. As the CBD’s use in topical applications broadens, the category faces questions about efficacy and safety. For success in topical CBD, brands must understand how to effectively navigate the regulatory landscape, responsibly communicate benefits to consumers, and work with retailers that have a high profile.
Key Learning Objectives:
Who Should Attend:
Justin J. Prochnow
Greenberg Traurig LLP
Justin J. Prochnow assists companies with regulatory, business, and legal needs in the beverage, food, dietary supplement, cosmetic, medical device, and OTC industries. Justin works closely with companies to ensure regulatory compliance with statutes and regulations enforced by the Food and Drug Administration, the Federal Trade Commission, and other regulatory agencies. This includes the review of product labels, labeling, advertising, websites, and other marketing materials. Justin assists companies with responding to governmental and regulatory actions, including FDA inspections and warning letters, FTC Civil Investigative Demands, and ASRC and NAD cases. He prepares and reviews business documents for industry members, including consulting, manufacturing, supply, and distribution agreements. Justin and his team also defend industry companies from both governmental agencies and civil litigators in litigation ranging from breach of contract cases to the growing number of class actions alleging false and misleading advertising.
Peter Lio, MD
Clinical Assistant Professor of Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Peter Lio, MD, is a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine. Dr. Lio received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children’s Hospital, and obtained his Dermatology training at Harvard where he served as Chief Resident in Dermatology. While at Harvard, he received formal training in acupuncture. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and a founding partner of Medical Dermatology Associates of Chicago. He currently serves as a board member and scientific advisory committee member for the National Eczema Association. He is a member of the American Academy of Dermatology’s Atopic Dermatitis Expert Resource Group and a founding faculty member of the Integrative Dermatology Certificate Program. He has authored over 200 publications and 3 textbooks.
William Rowe is the Co-founder, President, and Chief Executive Officer of Nutrasource and its subsidiaries. A charismatic leader and visionary, Mr. Rowe’s executive guidance enables Nutrasource to successfully launch products and expand its businesses. With nearly 20 years of experience in commercializing innovative consumer health products, Mr. Rowe has been instrumental in designing and implementing clinical trial development and marketing strategies to help sponsors comply with regulatory requirements and uncover new market opportunities. Mr. Rowe has also led the acquisition of two subsidiaries. Under Mr. Rowe’s continued leadership and strategic vision, the company looks to an optimistic future, helping its valued customers commercialize their innovations to improve healthcare globally.
Douglas “Duffy” MacKay, ND
Senior Vice President, Scientific and Regulatory Affairs
CV Sciences Inc.
Douglas “Duffy” MacKay, ND, is senior vice president, scientific and regulatory affairs, for CV Sciences Inc., maker of PlusCBD. At CV Sciences, he is responsible for scientific and regulatory affairs functions that drive product quality, safety, and innovation. Duffy came to CV Sciences after a 10-year career with the Council for Responsible Nutrition (CRN) in Washington, DC, where he served as senior vice president of scientific and regulatory affairs. At CRN, he oversaw the scientific and regulatory affairs department, ensuring the association’s scientific, policy, and legislative positions were based on credible scientific rationale. Duffy serves as a member of the CRN Board of Directors, the American Botanical Council Advisory Board, and the Food and Drug Law Institute’s Cannabis-Derived Products Committee. In addition, he is an associate editor of the Journal of Dietary Supplements and serves on the editorial boards of Integrative Medicine: A Clinician’s Journal and the Natural Medicine Journal. Duffy earned his naturopathic medical degree from the National University of Natural Medicine in Portland, OR.